MYRIAD GENETICS INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Myriad Genetics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q2 2024.
Myriad Genetics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$36.5M, a 67.9% increase year-over-year.
Myriad Genetics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$156M, a 40.7% increase year-over-year.
Myriad Genetics Inc annual Operating Income (Loss) for 2023 was -$257M, a 83.1% decline from 2022.
Myriad Genetics Inc annual Operating Income (Loss) for 2022 was -$141M, a 26.2% increase from 2021.
Myriad Genetics Inc annual Operating Income (Loss) for 2021 was -$191M, a 34.2% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$156M	-$36.5M	+$77.2M	+67.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$233M	-$27.9M	+$24.3M	+46.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	-$257M	-$31.4M	+$20.8M	+39.8%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	-$278M	-$60.1M	-$15.1M	-33.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	-$263M	-$114M	-$95.9M	-539%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$167M	-$52.2M	-$26.6M	-104%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	-$141M	-$52.2M	-$9.1M	-21.1%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	-$132M	-$45M	+$34.9M	+43.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	-$166M	-$17.8M	+$3M	+14.4%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	-$169M	-$25.6M	+$21.1M	+45.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	-$191M	-$43.1M	+$5.1M	+10.6%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	-$196M	-$79.9M	-$40.3M	-102%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	-$155M	-$20.8M	+$47.5M	+69.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	-$203M	-$46.7M	+$87M	+65.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	-$290M	-$48.2M	-$39.4M	-448%	Oct 1, 2020	Dec 31, 2020	10-KT	2021-03-16
Q3 2020	-$250M	-$39.6M	-$18.7M	-89.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	-$232M	-$68.3M	-$62.7M	-1120%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	-$169M	-$134M	-$140M	-2366%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	-$29.4M	-$8.8M	-$14.9M	-244%	Oct 1, 2019	Dec 31, 2019	10-KT	2021-03-16
Q3 2019	-$14.5M	-$20.9M	-$22.1M	-1842%	Jul 1, 2019	Sep 30, 2019	10-KT	2021-03-16
Q2 2019	$7.6M	-$5.6M	-$23.4M	-131%	Apr 1, 2019	Jun 30, 2019	10-KT	2021-03-16
Q1 2019	$31M	$5.9M	-$7.9M	-57.2%	Jan 1, 2019	Mar 31, 2019	10-KT	2021-03-16
Q4 2018	$38.9M	$6.1M	-$200K	-3.18%	Oct 1, 2018	Dec 31, 2018	10-KT	2021-03-16
Q3 2018	$39.1M	$1.2M	-$82.8M	-98.6%	Jul 1, 2018	Sep 30, 2018	10-KT	2021-03-16
Q2 2018	$122M	$17.8M	-$1.1M	-5.82%	Apr 1, 2018	Jun 30, 2018	10-K	2019-08-13
Q1 2018	$123M	$13.8M	+$8.3M	+151%	Jan 1, 2018	Mar 31, 2018	10-K	2019-08-13
Q4 2017	$115M	$6.3M	-$10.9M	-63.4%	Oct 1, 2017	Dec 31, 2017	10-K	2019-08-13
Q3 2017	$126M	$84M	+$76.9M	+1083%	Jul 1, 2017	Sep 30, 2017	10-K	2019-08-13
Q2 2017	$48.7M	$18.9M	-$3.4M	-15.2%	Apr 1, 2017	Jun 30, 2017	10-K	2018-08-24
Q1 2017	$52.1M	$5.5M	-$37.1M	-87.1%	Jan 1, 2017	Mar 31, 2017	10-K	2018-08-24
Q4 2016	$89.2M	$17.2M	-$28M	-61.9%	Oct 1, 2016	Dec 31, 2016	10-K	2018-08-24
Q3 2016	$117M	$7.1M	-$36.2M	-83.6%	Jul 1, 2016	Sep 30, 2016	10-K	2018-08-24
Q2 2016	$153M	$22.3M	-$13.4M	-37.5%	Apr 1, 2016	Jun 30, 2016	10-K	2018-08-24
Q1 2016	$167M	$42.6M	+$6.9M	+19.3%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	$160M	$45.2M	+$8.9M	+24.5%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-08
Q3 2015	$151M	$43.3M	+$17.4M	+67.2%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-02
Q2 2015	$134M	$35.7M	-$17.5M	-32.9%	Apr 1, 2015	Jun 30, 2015	10-K	2018-08-24
Q1 2015	$151M	$35.7M	-$19.6M	-35.4%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-04
Q4 2014	$171M	$36.3M	-$46.7M	-56.3%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-03
Q3 2014	$217M	$25.9M	-$57M	-68.8%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-04
Q2 2014	$274M	$53.2M	-$12.7M	-19.3%	Apr 1, 2014	Jun 30, 2014	10-K	2016-08-10
Q1 2014	$287M	$55.3M	-$2.63M	-4.54%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$290M	$83M	+$27.4M	+49.3%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-04
Q3 2013	$262M	$82.9M	+$34.3M	+70.6%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-05
Q2 2013	$228M	$65.9M	+$18.6M	+39.4%	Apr 1, 2013	Jun 30, 2013	10-K	2015-08-12
Q1 2013	$209M	$57.9M	+$11.8M	+25.6%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-07
Q4 2012	$198M	$55.6M	+$10.1M	+22.3%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-05
Q3 2012	$187M	$48.6M	+$7.11M	+17.1%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-12
Q2 2012	$180M	$47.3M	+$5.51M	+13.2%	Apr 1, 2012	Jun 30, 2012	10-K	2014-08-13
Q1 2012	$175M	$46.1M	+$4.27M	+10.2%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-08
Q4 2011	$171M	$45.5M	+$6.88M	+17.8%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-06
Q3 2011	$164M	$41.5M	+$5.88M	+16.5%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-09
Q2 2011	$158M	$41.8M			Apr 1, 2011	Jun 30, 2011	10-K	2013-08-14
Q1 2011		$41.8M	+$8.6M	+25.9%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-02
Q4 2010		$38.6M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-01
Q3 2010		$35.6M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-02
Q1 2010		$33.2M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.